G
SCYX icon

Gainplan’s SCYNEXIS SCYX Stock Holding History

Gainplan’s Portfolio SCYX Stock Details SCYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-775
Closed -$198K – 20
2016
Q4 		$198K Buy
+775
New +$227K 0.12% 10

Other funds holding SCYX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Gainplan's SCYX Position: Q1 2017 in Review

Gainplan sold out of SCYNEXIS (SCYX) in Q1 2017, closing a stake of 775 shares — an estimated $198K sold.

Gainplan first reported a position in SCYX in Q4 2016 and held it in 1 quarter. The position peaked at $198K in Q4 2016. 34 funds tracked by Wall St. Rank hold SCYX as of Q1 2017.

  • Gainplan reported no remaining SCYNEXIS position as of Q1 2017 after selling out during the quarter.
  • Gainplan sold 775 SCYNEXIS shares in Q1 2017, an estimated $198K.
  • Gainplan first reported a position in SCYNEXIS in Q4 2016 and held it in 1 quarter.
  • Gainplan's SCYNEXIS position peaked at $198K in Q4 2016.
  • 34 funds tracked by Wall St. Rank held SCYNEXIS as of Q1 2017.

Based on Gainplan's 13F filing for Q1 2017, filed 12 May 2017.